Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Soft Contact Lenses in Symptomatic Patients
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
The objective of the study was to clinically evaluate the safety and effectiveness of a new multi-purpose disinfecting solution for soft contact lenses in patients who experience discomfort with their contact lenses.
Clinical Evaluation of the Safety and Efficacy of an Investigational Multi-Purpose Disinfecting Solution Compared to a Marketed Multi-Purpose Solution for Care of Soft Contact Lenses in Symptomatic Patients
Study Start Date
Primary Completion Date
Study Completion Date
Resource links provided by the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Symptomatic for contact lens related discomfort at the end of the lens wearing day.
Successful daily wear of FDA Group IV lenses on a two-week or longer replacement schedule for at least two weeks.
Use of a multi-purpose solution only as the pre-study care regimen for at least one month (rewetting drops use is also acceptable).
Successful lens wear for at least 4 hours per day.
Vision correctable to 20/30.
Normal eyes - no current ocular abnormalities that prevent successful contact lens wear.
No corneal surgery within the past 12 months.
No systemic disease that affects that eye or that could be worsened by the use of contact lenses or solutions.
No over-the-counter or prescription ocular medication.
No enrollment in another clinical study within 30 days prior to enrollment.